Hansoh Pharmaceutical Group Company Limited
3692
株式のランク
#905
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
株価
$4.44
時価総額
$26.90B
変化（1日）
9.26%
変化（1年）
-5.38%
国
CN
取引 Hansoh Pharmaceutical Group Company Limited (3692)
カテゴリー
Healthcare
Hansoh Pharmaceutical Group Company Limited（3692）の配当履歴
Hansoh Pharmaceutical Group Company Limited（証券コード：3692）は合計で8回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：$1.00
配当利回り（TTM）：0.0154
すべての配当の合計（株式分割調整済み）は：$1.00
配当利回り（TTM）：0.0154
2021から2026までのHansoh Pharmaceutical Group Company Limited（3692）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 2026 (TTM) | $0.2316 | -36.88% |
| 2025 | $0.3669 | 6.91% |
| 2024 | $0.3432 | 184.34% |
| 2023 | $0.1207 | 34.11% |
| 2022 | $0.09 | 16.73% |
| 2021 | $0.0771 | 0.00% |
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 2026 (TTM) | $0.2316 | -36.88% |
| 2025 | $0.3669 | 6.91% |
| 2024 | $0.3432 | 184.34% |
| 2023 | $0.1207 | 34.11% |
| 2022 | $0.09 | 16.73% |
| 2021 | $0.0771 | 0.00% |
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 38.00% |
IN
|
